Table 4.
Multivariable analysis of breast cancer-specific survival
| n | HR (95% CI) | p-value | |
|---|---|---|---|
| Multivariable analysis of breast cancer specific survival | |||
| Tumour subtype | |||
| Luminal A-like | 264 | Ref. | |
| Luminal B-like (HER2−) | 125 | 1.53 (0.70–3.33) | 0.28 |
| Triple negative | 30 | 1.89 (0.60–5.93) | 0.27 |
| HER2-positive | 26 | 1.23 (0.28–5.40) | 0.79 |
| Clinical detectiona | 129 | 1.46 (0.69–3.06) | 0.32 |
| Tumour size (mm) | 1.08 (0.96–1.21) | 0.21 | |
| Age (years) | 0.99 (0.96–1.02) | 0.47 | |
n number of patients with risk factor, HR hazard ratio, Ref. reference, CI confidence interval
aCompared to detection by screening